Joshua P Havens

12PUBLICATIONS
57CO-AUTHORS
Major global burdens of diseaseInfectious diseasesPsychiatry (incl. psychotherapy)Foetal development and medicineBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 31, 2026
Financial Impact of a Long-Acting Injectable Cabotegravir/Rilpivirine Program: A Real-World Experience.

|Apr 22, 2026
Ensitrelvir for the Treatment of Hospitalized Adults With COVID-19: An International Phase 3 Randomized Placebo-controlled Trial.

|Mar 16, 2026
Scalability Metrics and Effort Requirements for a Long-Acting Injectable Antiretroviral Treatment Program.

Joshua P Havens, Jennifer O'Neill, Maureen Kubat

|Nov 10, 2025
Long-acting Cabotegravir/Rilpivirine for Treatment of HIV During Pregnancy: A Case Series.

Shawnalyn W Sunagawa, Carly Cloud Floyd, Sara H Bares

|Jul 24, 2025
Sustained HIV Viral Suppression 18 Months After the Last Dose of Long-acting Cabotegravir/Rilpivirine: A Case Report.

Shawnalyn W Sunagawa, Sara H Bares, Kimberly K Scarsi

|Jul 02, 2025
Implementation of an Online Drug-Drug Interaction Screener for the STRIVE Ensitrelvir Trial for COVID-19.

Joshua P Havens, Nayon Kang, Lucy Chung

Pageof 2

Frequent Collaborators

5 joint publications

Sara H Bares

5 joint publications

Shawnalyn W Sunagawa

4 joint publications

Jennifer M Davis

4 joint publications

Nada Fadul